课题基金 / 基金详情

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type
HLA-A3超型受试者T细胞介导的抗原识别的分子基础研究
批准号:
18310147
负责人:
ITOH Kyogo
金额:
$11.72万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

ITOH Kyogo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Cancer associated antigen-derived peptides: We have identified new peptides from SART3 and Lck antigens that are recognized by HLA-A3 super family-restricted cytotoxic T lymphocytes (CTL) (Minami, et. Al., Cancer Immunol. Immunoth.: Naito, et. Al., Brit.J.Can. 2007).2. Exogenous antigen-derived peptides: We have identified new peptides from hepatitis C virus sequences that are recognized by HLA-A3 super family-restricted CTL (Matsueda, et. Al., Cancer Immunol Immunotherapy, 2007). Furthermore, we found that measurement of lgG antibodies specific to core region of hepatitis C virus at positions 35-44 (C35-44) is a possible new diagnostic tool of hepatitis C virus infection (Takao, et. Al., Med. Mirobiol. Immunol., 2007).3. Self antigen-derived peptides: We have identified new peptides from self antigens that are recognized by HLA-A3 super family-restricted CTL (Matsueda, et. Al., J. Immunotherpy 2007).4. Summary: We have obtained new evidence during the past two years with regard to molecular basis of T cell-mediated recognition of antigens in both healthy donors and cancer patients belonging to HLA-A3 super type (HLA-A3,-A 11, -A31, and-A33). The binding motifs of these newly identified peptides to HLA-class IA alleles of HLA-A3 super type were mostly unpredictable from the currently available database of MHC binding peptides predicting the binding of peptides to HLA-class IA alleles of A3 super type. These results indicate that the binding motifs of CTL epitopes to HLA-class IA alleles of HLA-A3 super type are different form those expected in the past. The results created in this grant shall facilitate to better understanding of host responses to cancer cells as well as viral antigens in subjects of HLA-A3 super type, and may contribute to development of new database of MHC binding peptides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
鉴定具有在人类白细胞抗原 A24 和 HCV2a 感染患者中诱导细胞毒性 T 淋巴细胞能力的丙型肝炎病毒 (HCV) 2a 衍生表位肽。
DOI: --
发表时间: 2006
期刊: Cell Immunol. 241
影响因子: --
作者: [Wang Y, Itoh K et al.]
通讯作者: Itoh K et al.
Identification of SART3-dehved peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles
鉴定具有从具有 HLA-A3 超型等位基因的前列腺癌患者中诱导癌症反应性细胞毒性 T 淋巴细胞的潜力的 SART3 衍生肽
DOI: --
发表时间: 2007
期刊: Cancer Immunol Immunother 56
影响因子: --
作者: [Minami T, Itoh K, et. al.]
通讯作者: et. al.
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11,-A31 and -A33
一种源自丙型肝炎病毒 1b 的新表位肽,具有在 HCV1b 感染 HLA-A11、-A31 和 -A33 的患者中诱导细胞毒性 T 淋巴细胞的能力
DOI: --
发表时间: 2007
期刊: Cancer Immunol Immunother 56(9)
影响因子: --
作者: [Matsueda S, et. al.]
通讯作者: et. al.
Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.
个性化肽疫苗接种与低剂量雌莫司汀磷酸盐联合治疗转移性激素难治性前列腺癌患者:治疗中预后因素的分析。
DOI: --
发表时间: 2007
期刊: Oncol Res 16
影响因子: --
作者: [Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matuoka K]
通讯作者: Matuoka K
34
    Basic research of peptide vaccine as therapeutic cancer vaccine
    • 批准号:
      17016074
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $45.76万
    • 财政年份:
      2005
    • 负责人:
      ITOH Kyogo
    • 依托单位:
    Study of tumor associated antigens recognized by human CD8^+ cytotoxic T lymphocytes
    • 批准号:
      12213134
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $87.68万
    • 财政年份:
      2000
    • 负责人:
      ITOH Kyogo
    • 依托单位:
    Identification of genes encoding tumor-rejection antigens of cancers from digestive tract and development of cancer vaccine
    • 批准号:
      09470271
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.13万
    • 财政年份:
      1997
    • 负责人:
      ITOH Kyogo
    • 依托单位:
    Development of cancer vaccine with MAGE gene products.
    • 批准号:
      07457284
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.54万
    • 财政年份:
      1995
    • 负责人:
      ITOH Kyogo
    • 依托单位:
    国内基金
    海外基金
    基于CRISPR/Cas9文库筛选蜱传病毒Tamdy virus感染相关宿主因子及其作用机制的研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      周宏
    • 依托单位:
    DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
    基于寨卡病毒NS1和NS5的海洋微生物中抗病毒化合物的发现
    • 批准号:
      81973204
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2019
    • 负责人:
      宋福行
    • 依托单位:
    苹果茎沟病毒(Apple stem grooving virus, ASGV)CP基因介导的RNAi 转基因对ASGV侵染和脱毒的影响研究
    • 批准号:
      31801709
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2018
    • 负责人:
      冯超红
    • 依托单位: